98%
921
2 minutes
20
Percutaneous coronary intervention (PCI) of multiple chronic total occlusions (CTOs) during a single procedure is infrequently performed and remains understudied. We compared the characteristics and outcomes of patients who underwent multiple versus single CTO PCIs during the same procedure. We analyzed data from 16,550 patients (16,876 CTO PCIs) from a large, multicenter registry. PCI of multiple CTOs was attempted in 626 lesions (3.7%) in 304 patients: 289 patients (95.1%) underwent PCI of 2 CTOs, 15 patients underwent PCI of 3 CTOs (4.9%) and 1 of 4 CTOs. Single CTO PCI was attempted in 16,246 patients. These patients had more comorbidities and more complex lesions, with higher prevalence of moderate or severe calcification and tortuosity, higher PROGRESS-CTO scores (1.56 vs 1.22, p <0.001), but similar J-CTO scores (2.46 vs 2.38, p = 0.110). Technical (84.7% vs 87.3%, p = 0.215) and procedural (83.0% vs 86.0%, p = 0.163) success were similar. Patients who underwent PCI of multiple CTOs required longer procedure and fluoroscopy times and higher contrast volume and use of percutaneous ventricular assistance devices (pVAD) (9.2% vs 1.8%, p <0.001). The incidence of major adverse cardiovascular events (MACE) was similar (2.6% vs 1.9%, p = 0.372). In patients who underwent PCI of multiple CTOs during the same procedure, subsequently treated CTOs had higher complexity compared with the initially treated CTO. Despite higher complexity, attempting PCI of multiple CTOs during the same procedure was associated with similar outcomes, but higher use of radiation, contrast and pVAD compared with PCI of single CTOs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.amjcard.2025.07.037 | DOI Listing |
Mult Scler
September 2025
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Background: Tumefactive demyelination (TD) is a rare variant of multiple sclerosis (MS) characterized by tumor-like lesions that often require aggressive management. Genome-wide association studies (GWAS) identified variants associated with MS; similar analyses in TD are lacking.
Objective: A GWAS was performed to identify variants associated with TD.
Clin Nucl Med
September 2025
Departments of Nuclear Medicine.
This image highlights a diagnostic pitfall in a 65-year-old patient with recurrent glioblastoma. 18F-FET-PET revealed 2 hotspots with focally enhanced uptake: local tumor recurrence (TBRmax 2.3) on the left and another lesion in the right anterior cingulate gyrus (TBRmax 1.
View Article and Find Full Text PDFPediatr Blood Cancer
September 2025
Acute Myeloid Leukemia Sub-Committee, Association of Childhood Leukemia Study (JACLS), Japan.
Background: Relapsed or refractory cases of pediatric acute myeloid leukemia (AML) have poor outcomes despite advancements in chemotherapy and hematopoietic stem cell transplantation (HSCT). While a second HSCT is often a salvage option, its outcomes vary widely, and prognostic factors remain unclear.
Objectives: This study aimed to evaluate outcomes and identify prognostic factors in pediatric patients with AML who underwent multiple HSCTs.
J Neurooncol
September 2025
Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Purpose: We report outcomes of repeat stereotactic radiosurgery (rSRS) to sites of tumor progression following initial SRS. Additionally, we sought to determine if, at the time of recurrence following initial SRS, surgical resection of the tumor followed by SRS (surgery + rSRS) provided benefit compared to rSRS alone.
Methods: We retrospectively reviewed patients treated with rSRS for local recurrence after initial SRS.
Surgeon
September 2025
Department of Vascular and Endovascular Surgery, Waterford University Hospital, Waterford, Ireland; University College Cork, Ireland; Department of Vascular and Endovascular Surgery, Faculty of Medicine, Mansoura University, Mansoura, Egypt. Electronic address:
Background: The management of diabetic foot infections (DFIs) is a complex multidisciplinary process and often necessitates surgical interventions. Unfortunately, amputations such as single or multiple toes amputations (MTA) or full transmetatarsal amputation (TMA) are often the unavoidable solution. This study aimed to compare the clinical outcomes of TMA versus MTA in managing non-ischemic diabetic foot infections.
View Article and Find Full Text PDF